| BAPP | beta amyloid precursor protein |
|---|---|
| BAR | bariatrics; barometer, barometric; beta-adrenergic receptor |
| BARK | beta-adrenergic receptor kinase |
| BAS | balloon atrial septostomy; benzyl anti-serotinin; beta-adrenergic stimulation; boric acid solution |
| BELIR | beta-endorphin-like immunoreactivity |
| 11 beta-HSD-1 | 11 beta-Hydroxysteroid dehydrogenase type 1 |
|---|---|
| 11 beta-HSD2 | 11 beta-Hydroxysteroid dehydrogenase type 2 |
| 17 beta-HSD | 17 Beta-Hydroxysteroid dehydrogenase |
| 17,20 beta-P | 17 alpha, 20 beta-dihydroxy-4-pregnen-3-one |
| 17 beta-HSOR | 17 beta-Hydroxysteroid oxidoreductase |
| nasal provocation tests | Application of allergens to the nasal mucosa. Interpretation includes observation of nasal symptoms, rhinoscopy, and rhinomanometry. Nasal provocaton tests are used in the diagnosis of nasal hypersensitivity, including hay fever. (12 Dec 1998) |
|---|---|
| neuropsychological tests | Tests designed to assess neurological function associated with certain behaviours. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. (12 Dec 1998) |
| neutralization tests | Titration of an antiserum by testing a series of dilutions of virus or immune serum to a given end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (cpe) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (id50) or die (ld50). (12 Dec 1998) |
| diagnostic tests, routine | Diagnostic procedures, such as laboratory tests and X-rays, routinely performed on all individuals or specified categories of individuals in a specified situation, e.g., patients being admitted to the hospital. These include routine tests administered to neonates. (12 Dec 1998) |
| dichotic listening tests | Tests for central hearing disorders based on the competing message technique (binaural separation). (12 Dec 1998) |
| immunologic tests | Diagnostic techniques involving the demonstration or measurement of an immune response, including antibody production or assay, antigen-antibody reactions, serologic cross-reactivity, delayed hypersensitivity reactions, or heterogenetic responses. (12 Dec 1998) |
| ink blot tests | Projective tests utilizing ink blots to which a subject responds. They are used in personality diagnosis. (12 Dec 1998) |
| intradermal tests | Skin tests in which the sensitiser is injected. (12 Dec 1998) |
| ovarian function tests | Methods used for assessment of ovarian function. (12 Dec 1998) |
| tests of criminal responsibility | In forensic psychiatry, legal precedents upon which are based decisions concerning insanity in criminals. See: American Law Institute rule, Durham rule, M'Naghten rule, New Hampshire rule. (05 Mar 2000) |
| toxicity tests | Tests that determine the toxicity of a substance. These include tests of clinical drugs, foods, environmental pollutants, etc. (12 Dec 1998) |
| fallopian tube patency tests | Methods for assessing the patency of the fallopian tubes. (12 Dec 1998) |
| flocculation tests | Precipitin tests in which precipitation occurs over a narrow range of antigen-antibody ratio, due chiefly to peculiarities of the antibody (precipitin). (12 Dec 1998) |
| language tests | Tests designed to assess language behaviour and abilities. They include tests of vocabulary, comprehension, grammar and functional use of language, e.g., development sentence scoring, receptive-expressive emergent language scale, parsons language sample, utah test of language development, michigan language inventory and verbal language development scale, illinois test of psycholinguistic abilities, northwestern syntax screening test, peabody picture vocabulary test, ammons full-range picture vocabulary test, and assessment of children's language comprehension. (12 Dec 1998) |
| latex fixation tests | Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (12 Dec 1998) |